RBP4 Pty Ltd: Clinical Trials

3 trials sponsored by RBP4 Pty Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Completed 1

Follow RBP4 Pty Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85
Tinlarebant (LBS-008) - Healthy Volunteer, Dry Age-related Macular Degeneration
Phase 1CompletedRBP4 Pty Ltd152022-11-282023-02-23
This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease
tinlarebant - Stargardt Disease
Phase 1 / Phase 2CompletedRBP4 Pty Ltd132021-03-122024-04-12
Safety and Tolerability Study of LBS-008 in Healthy Adult Subjects After Single and Multiple Doses
LBS-008, Placebos - Healthy Volunteer
Phase 1CompletedRBP4 Pty Ltd712018-11-152020-01-07

Conditions studied

Stargardt Disease (1)

Countries

Australia (3)  ·  Taiwan (1)

Top investigators

Sam Francis (1)